HOME >> MEDICINE >> NEWS
Sprinklers shown effective in slowing dorm fires

An automatic sprinkler system significantly increases a person's chances of surviving a dormitory fire, according to a report issued recently by the National Institute of Standards and Technology (NIST).

Three NIST experiments,* supported by a U.S. Fire Administration (USFA) initiative for fire safety in college housing, compared the hazards of fires in smoke detector-equipped dormitories with and without fire sprinklers in the room of fire origin. Researchers started fires in a day room or lounge area open to the corridor of a dormitory. They used the temperature of 120 degrees C (248 degrees F) as the cutoff mark for human survival. For comparison, the temperature of boiling water is 100 degrees C.

In two experiments without sprinklers, potentially fatal temperatures exceeding 120 degrees C as well as toxic gases reached a remote corridor 22.9 meters (75 feet) away within three minutes and completely spread throughout the corridor within another three minutes. In an experiment with sprinklers, temperatures at the 1.5 meter (five feet) level and below in the room where the fire began never exceeded 120 degrees C. No significant increase in heat was measured in the corridor during the experiment, allowing adequate time for residents to escape.

NIST conducted the experiments at a barracks donated by the Myrtle Beach Air Force Base Redevelopment Authority in Myrtle Beach, S.C. The USFA incorporated footage of NIST sprinkler tests into a fire safety video for college administrators and students.


'"/>

Contact: John Blair
john.blair@nist.gov
301-975-4261
National Institute of Standards and Technology (NIST)
11-Feb-2005


Page: 1

Related medicine news :

1. Cartilage repair techniques shown to restore patient mobility and reduce pain
2. Controversial drug shown to act on brain protein to cut alcohol use
3. HPV vaccine shown effective at reducing cancer-causing infections
4. HPV vaccine shown to substantially reduce cervical cancer
5. New research results: Heart jacket shown to be effective
6. Pioglitazone shown to reverse thickening of carotid artery wall
7. Isolated soy protein shown to benefit type 2 diabetics, study indicates
8. Pioglitazone HCI shown to lower blood pressure in hypertensive patients with type 2 diabetes
9. Increased risk of cardiovascular disease shown in PCOS patients
10. Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia
11. Anti-eosinophil therapy shown to be effective in treating hypereosinophilic syndrome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with gluten intolerance ... you may be interested in participating in a research study that focuses on family ... understand more about the relational aspects of adults who have gluten sensitivities who cohabitate ...
(Date:8/19/2017)... York (PRWEB) , ... August 19, 2017 , ... ... has announced that it is the first organization with pending recognition status from ... Diabetes Prevention Program (“DPP”) via group telehealth classes and live video conferencing. ...
(Date:8/19/2017)... Fla. (PRWEB) , ... August 19, 2017 , ... ... Taufiq Ahmed, M.D., has joined its Orlando location as an interventional pain management ... anesthesiology, a focus on the treatment of migraine headaches, and significant experience in ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance ... a new charity drive to generate community support for efforts to educate the local ... and treatments for all types of cancer. , Each day in America, roughly ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
Breaking Medicine Technology:
Cached News: